☆ 4.6 Editorial Material

Cancer nanomedicines: oversold or underappreciated?

EXPERT OPINION ON DRUG DELIVERY (2017)

Get Full Text
Add to Collection

Journal

EXPERT OPINION ON DRUG DELIVERY
Volume 14, Issue 1, Pages 1-5

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/17425247.2017.1262346

Keywords

Cancer nanomedicines; EPR effect; Clinical translation; Clinical trials; Drug targeting; Drug delivery; Combination treatment; Triggered release

Categories

Pharmacology & Pharmacy

Funding

  1. European Research Council [309495] Funding Source: Medline

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.